mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |